Mostrar el registro sencillo del ítem

dc.contributor.authorLópez Moreno, Ana 
dc.contributor.authorAguilera Gómez, Margarita 
dc.date.accessioned2020-06-10T12:38:56Z
dc.date.available2020-06-10T12:38:56Z
dc.date.issued2020-03
dc.identifier.citationLópez-Moreno, A., & Aguilera, M. (2020). Probiotics Dietary Supplementation for Modulating Endocrine and Fertility Microbiota Dysbiosis. Nutrients, 12(3), 757. [doi:10.3390/nu12030757]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/62425
dc.descriptionAna López Moreno and Margarita Aguilera are part of the BIO-190 Research Group. They are also part of “UGR Plan Propio de Investigación 2019–2020.es_ES
dc.description.abstractHuman microbiota seems to play a key role in endocrine and reproductive systems. Fortunately, microbiota reproductive dysbiosis start to be treated by probiotics using typical species from genus Lactobacillus. This work presents the compiled and analysed results from the most up-to-date information from clinical trials regarding microbiota, fertility, probiotics and oral route administration, reviewing open access scientific documents. These studies analyse the clinical impact of probiotics administered on several endocrine disorders’ manifestations in women: mastitis; vaginal dysbiosis; pregnancy complication disorders; and polycystic ovary syndrome. In all cases, the clinical modulation achieved by probiotics was evaluated positively through the improvement of specific disease outcomes with the exception of the pregnancy disorders studies, where the sample sizes results were statistically insufficient. High amounts of studies were discarded because no data were provided on specific probiotic strains, doses, impact on the individual autochthon microbiota, or data regarding specific hormonal values modifications and endocrine regulation effects. However, most of the selected studies with probiotics contained no protocolised administration. Therefore, we consider that intervention studies with probiotics might allocate the focus, not only in obtaining a final outcome, but in how to personalise the administration according to the disorder to be palliated.es_ES
dc.description.sponsorshipThis research received no direct external funding. A.L.M. was granted with the IniciaTC programme—OTRI-UGR in collaboration with Fertypharm S.L.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectProbioticses_ES
dc.subjectDoseses_ES
dc.subjectMicrobiotaes_ES
dc.subjectEndocrinees_ES
dc.subjectFertility es_ES
dc.subjectDysbiosises_ES
dc.titleProbiotics Dietary Supplementation for Modulating Endocrine and Fertility Microbiota Dysbiosises_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doidoi:10.3390/nu12030757


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España